Skip to content

China Shineway Pharmaceutical Group Ltd Sustainability Reports

The company operates as an investment holding company engaged in the research, development, manufacturing, and trading of modern Chinese medicines, including injections, soft capsules, and granules.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 5299001VVE1YDGPXXR74

FIGI: BBG001S8S9B7

17 reports from 2013 to 2025